Pharmadrug Inc.
PHRX
CNSX
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 13.00K | 52.00K | 52.20K | 94.80K | 109.30K |
Total Receivables | 11.50K | 6.40K | 16.00K | 12.20K | 44.60K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | 3.50K | 9.30K | 40.70K | 40.20K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 3.90K | 14.70K | 24.80K | -- | -- |
Total Current Assets | 28.40K | 76.50K | 102.20K | 147.80K | 194.00K |
|
|||||
Total Current Assets | 28.40K | 76.50K | 102.20K | 147.80K | 194.00K |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Other Intangibles | 395.60K | 384.10K | 392.50K | 416.20K | 422.20K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | 2.20K | -- |
Total Assets | 424.10K | 460.70K | 494.70K | 566.20K | 616.20K |
|
|||||
Total Accounts Payable | 380.10K | 432.50K | 257.20K | 253.80K | 257.80K |
Total Accrued Expenses | 35.60K | -- | 164.80K | 241.90K | 238.80K |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 1.05M | 959.90K | 937.50K | 1.04M | 978.50K |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 1.47M | 1.39M | 1.36M | 1.53M | 1.48M |
|
|||||
Total Current Liabilities | 1.47M | 1.39M | 1.36M | 1.53M | 1.48M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 1.47M | 1.39M | 1.36M | 1.53M | 1.48M |
|
|||||
Common Stock & APIC | 24.94M | 23.66M | 23.62M | 25.20M | 24.85M |
Retained Earnings | -28.80M | -27.28M | -27.18M | -28.94M | -28.44M |
Treasury Stock & Other | 2.72M | 2.58M | 2.58M | 2.64M | 2.60M |
Total Common Equity | -1.14M | -1.03M | -975.30K | -1.09M | -991.80K |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -1.14M | -1.03M | -975.30K | -1.09M | -991.80K |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | 95.20K | 98.80K | 110.50K | 127.40K | 132.80K |
Total Equity | -1.04M | -931.70K | -864.80K | -967.10K | -858.90K |
|